Pat Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-12-2024
- Paid Up Capital ₹ 0.10 M
as on 04-12-2024
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.90 M
as on 04-12-2024
- Revenue 1.68%
(FY 2022)
- Profit -30.99%
(FY 2022)
- Ebitda -32.48%
(FY 2022)
- Net Worth 9.56%
(FY 2022)
- Total Assets 30.22%
(FY 2022)
About Pat Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.90 M.
Manohar Patwardhan, Nayan Patwardhan, and Abhishek Patwardhan serve as directors at the Company.
- CIN/LLPIN
U24233MH2015PTC263954
- Company No.
263954
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Pat Pharmaceuticals Private Limited offer?
Pat Pharmaceuticals Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine.
Who are the key members and board of directors at Pat Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhishek Patwardhan  | Director | 30-Apr-2015 | Current |
| Manohar Patwardhan | Director | 30-Apr-2015 | Current |
| Nayan Patwardhan | Director | 30-Apr-2015 | Current |
Financial Performance of Pat Pharmaceuticals.
Pat Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 1.68% increase. The company also saw a substantial fall in profitability, with a 30.99% decrease in profit. The company's net worth moved up by a moderate rise of 9.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pat Pharmaceuticals?
In 2020, Pat Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Limited Creation Date: 29 Jul 2019 | ₹0.90 M | Open |
How Many Employees Work at Pat Pharmaceuticals?
Unlock and access historical data on people associated with Pat Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pat Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pat Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
